Literature DB >> 19700745

Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.

Bettina Sobottka1, Melanie Denise Harrer, Urs Ziegler, Katja Fischer, Heinz Wiendl, Thomas Hünig, Burkhard Becher, Norbert Goebels.   

Abstract

Permanent disability of patients suffering from central nervous system (CNS) inflammation such as multiple sclerosis, the most common chronic inflammatory disorder of the CNS, originates mainly from demyelination and axonal damage. Although many studies in the past focused on the role of CD4(+) T cells, several recent findings postulate the relevance of autoaggressive, cytotoxic CD8(+) T cells in the effector phase of multiple sclerosis. Yet, it remains unresolved whether axonal injury is the result of a CD8(+) T cell-targeted hit against the axon itself or the consequence of an attack against the myelin structure. To address this issue of CD8-mediated tissue damage in CNS inflammation, we performed continuous confocal imaging of autoaggressive, cytotoxic CD8(+) T cells in living organotypic cerebellar brain slices. We observed that loading brain slices with the cognate peptide antigen caused CD8-mediated damage of myelinated axons. To exclude the possibility that the cognate peptide loaded onto the brain slices was presented by axons directly, we restricted the cognate antigen expression exclusively to the cytosol of oligodendrocytes. Aside from vast myelin damage, extensive axonal bystander injury occurred. Using this model system of inflammatory CNS injury, we visualize that axonal loss can be the consequence from "collateral bystander damage" by autoaggressive, cytotoxic CD8(+) T cells, targeting their cognate antigen processed and presented by oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700745      PMCID: PMC2731134          DOI: 10.2353/ajpath.2009.090340

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Multiple sclerosis: a two-stage disease.

Authors:  L Steinman
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

2.  Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes.

Authors:  I Medana; M A Martinic; H Wekerle; H Neumann
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

3.  Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold.

Authors:  Mustapha Faroudi; Clemens Utzny; Mariolina Salio; Vincenzo Cerundolo; Martine Guiraud; Sabina Müller; Salvatore Valitutti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

4.  Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes.

Authors:  Yi Cao; Catherine Toben; Shin-Young Na; Kirsten Stark; Lars Nitschke; Alan Peterson; Ralf Gold; Anneliese Schimpl; Thomas Hünig
Journal:  Eur J Immunol       Date:  2006-01       Impact factor: 5.532

5.  Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue.

Authors:  Robert Nitsch; Elena E Pohl; Alina Smorodchenko; Carmen Infante-Duarte; Orhan Aktas; Frauke Zipp
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 6.  Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

Authors:  Harald Neumann; Isabelle M Medana; Jan Bauer; Hans Lassmann
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

7.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors:  Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

8.  High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay.

Authors:  Michael P Crawford; Shirley X Yan; Sterling B Ortega; Riyaz S Mehta; Rachel E Hewitt; David A Price; Peter Stastny; Daniel C Douek; Richard A Koup; Michael K Racke; Nitin J Karandikar
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

9.  Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction.

Authors:  H Babbe; A Roers; A Waisman; H Lassmann; N Goebels; R Hohlfeld; M Friese; R Schröder; M Deckert; S Schmidt; R Ravid; K Rajewsky
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

10.  A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis.

Authors:  E S Huseby; D Liggitt; T Brabb; B Schnabel; C Ohlén; J Goverman
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

View more
  36 in total

1.  Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

2.  Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells.

Authors:  A Møller-Larsen; T Brudek; T Petersen; E L Petersen; M Aagaard; D T Hansen; T Christensen
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

Review 3.  Guillain-barré syndrome: modern theories of etiology.

Authors:  Todd A Hardy; Stefan Blum; Pamela A McCombe; Stephen W Reddel
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 4.  Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

Authors:  Tobias Derfuss; Chris Linington; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Mol Med (Berl)       Date:  2010-05-06       Impact factor: 4.599

5.  Axonal damage in multiple sclerosis.

Authors:  Jeffery D Haines; Matilde Inglese; Patrizia Casaccia
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

Review 6.  CD8(+) T cells in multiple sclerosis.

Authors:  Aleksandar Denic; Bharath Wootla; Moses Rodriguez
Journal:  Expert Opin Ther Targets       Date:  2013-07-06       Impact factor: 6.902

Review 7.  Induced Stem Cells as a Novel Multiple Sclerosis Therapy.

Authors:  Chong Xie; Yan-Qun Liu; Yang-Tai Guan; Guang-Xian Zhang
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

8.  CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis.

Authors:  Chandra Deb; Reghann G Lafrance-Corey; William F Schmalstieg; Brian M Sauer; Huan Wang; Christopher L German; Anthony J Windebank; Moses Rodriguez; Charles L Howe
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

Review 9.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

10.  Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism.

Authors:  Brian M Sauer; William F Schmalstieg; Charles L Howe
Journal:  Neurobiol Dis       Date:  2013-07-27       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.